News Quantified

BDMD – baird medical investment holdings ltd - ordinary share (US:NASDAQ)

Stock Stats

News Stats

Order Stats

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion

Baird Medical Enters Egyptian Market with First Successful Bone Tumor Ablation

Baird Medical Investment (NASDAQ:BDMD) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.

Baird Medical's MWA System Achieves Successful Medicare Reimbursement at Prominent New York Practice

Baird Medical Announces First Successful Liver Tumor Ablation in Bangladesh

Form F-1/A Baird Medical Investment

Form 6-K Baird Medical Investment For: Jun 30

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}